Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
Chimeric antigen receptors (CAR) use antibody variable regions to activate anti-tumor immunity. Here the authors show that a mouse IgH/IgL variable region used in a clinical CAR induces host immune responses to possibly reduce therapy efficacy, but an IgH-only CAR T design achieves similar CAR T act...
Guardado en:
Autores principales: | Norris Lam, Nathan D. Trinklein, Benjamin Buelow, George H. Patterson, Namrata Ojha, James N. Kochenderfer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a25f26915c1c45269a9ab2d9dfccb998 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
por: Norris Lam, et al.
Publicado: (2020) -
A TCR-based Chimeric Antigen Receptor
por: Even Walseng, et al.
Publicado: (2017) -
Chimeric antigen receptor modified T-cells for cancer treatment
por: Xiao Han, et al.
Publicado: (2018) -
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
por: Chungyong Han, et al.
Publicado: (2018) -
Structure-based design of chimeric antigens for multivalent protein vaccines
por: S. Hollingshead, et al.
Publicado: (2018)